You have 9 free searches left this month | to do more

aflibercept

Aflibercept is a drug used to treat Diabetic Macular Edema, Age Related Macular Degeneration, Metastatic Colorectal Cancer, and other conditions. Aflibercept is being actively studied in 33 studies and prior, has been studied in 61.

Top SponsorsTop SitesTop Investigators
Novartis PharmaceuticalsSierra Eye AssociatesRishi Singh
Hoffmann-La RocheSoutheast Retina CenterCharles C Wykoff, PhD, MD
SanofiTexas Retina AssociatesJi Eun Lee
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Completed
  • Neovascular Glaucoma
  • Aflibercept
  • Aurora, Colorado
    Rocky Mountain Lions Eye Institute
2022-02-16
Feb 16, 2022
B
Not yet recruiting
  • Wet Age-related Macular Degeneration
  • Aflibercept
  • +2 more
  • (no location specified)
2022-03-02
Mar 2, 2022
Q
Recruiting
  • Non-Ischemic Central Retinal Vein Occlusion With Macular Edema
  • intravitreal injection of Ranibizumab
  • +3 more
  • Qinā, Qena, Egypt
    Ahmed Ali Ahmed Amer
2022-03-15
Mar 15, 2022
A
Active, not recruiting
  • Rectal Cancer
  • Rectosigmoid Cancer
  • Mannheim, Germany
    Tagestherapiezentrum am ITM & III. Med. Klinik
2021-12-14
Dec 14, 2021
L
Completed
  • Adverse Effect of Radiation Therapy
  • aflibercept
  • (no location specified)
2021-04-17
Apr 17, 2021
K
Completed
  • Age Related Macular Degeneration
  • London, UK, United Kingdom
    King's College Hospital NHS Foundation Trust
2021-04-29
Apr 29, 2021
M
Recruiting
  • Age Related Macular Degeneration
  • +2 more
  • Aflibercept
  • Vienna, Austria
    Medical University of Vienna
2021-03-16
Mar 16, 2021
S
Active, not recruiting
  • Metastatic Colorectal Cancer
  • Colorectal Neoplasms
  • (no location specified)
2021-12-17
Dec 17, 2021
R
Completed
  • Diabetic Retinopathy
  • Macular Edema
  • aflibercept
  • Cleveland, Ohio
    Cole Eye Institute, Cleveland Clinic
2021-01-25
Jan 25, 2021
C
Completed
  • Proliferative Diabetic Retinopathy
  • Aflibercept
  • Houston, Texas
  • +3 more
2021-05-20
May 20, 2021
A
Completed
  • Central Retinal Vein Occlusion
  • Stockholm, Sweden
    St Eriks Eye Hospital
2020-12-03
Dec 3, 2020
N
Withdrawn
  • Diabetic Macula Edema
  • (no location specified)
2021-03-02
Mar 2, 2021
T
Recruiting
  • Diabetic Macular Edema
  • Dexamethasone implant
  • Aflibercept
  • Houston, Texas
    Retina Consultants of Houston
2021-07-19
Jul 19, 2021
A
Active, not recruiting
  • Radiation Retinopathy
  • Aflibercept
  • Houston, Texas
  • +2 more
2020-12-07
Dec 7, 2020
S
Recruiting
  • Central Serous Chorioretinopathy
  • +2 more
  • aflibercept
  • Toronto, Ontario, Canada
    Sunnybrook Research Institute
2021-01-25
Jan 25, 2021
T
Terminated
  • Irvine-Gass Syndrome
  • Aflibercept
  • Boston, Massachusetts
    Tufts Medical Center
2020-08-19
Aug 19, 2020
J
Completed
  • Retinal Vein Occlusion
  • +3 more
  • Aflibercept
  • Cleveland, Ohio
    Cole Eye Institute, Cleveland Clinic
2021-05-10
May 10, 2021
C
Not yet recruiting
  • Wet Age-related Macular Degeneration
  • (no location specified)
2022-03-08
Mar 8, 2022
N
Active, not recruiting
  • Diabetic Macular Edema
  • Guangzhou, Guangdong, China
  • +23 more
2022-02-25
Feb 25, 2022
A
Completed
  • Neovascular Age-related Macular Degeneration
  • Beverly Hills, California
  • +20 more
2021-10-07
Oct 7, 2021
W
Recruiting
  • Neovascular Age-related Macular Edema
  • +5 more
  • Beijing, Beijing, China
    Wen-Bin Wei
2022-02-02
Feb 2, 2022
B
Terminated
  • Metastatic Colorectal Cancer
  • Aflibercept
  • Providence, Rhode Island
  • +1 more
2020-02-13
Feb 13, 2020
R
Terminated
  • Advanced Carcinoma
  • Non-small Cell Lung Cancer
  • Aflibercept
  • +2 more
  • Tucson, Arizona
  • +14 more
2020-11-13
Nov 13, 2020